Tag: Teva Pharmaceuticals (TEVA.NYSE)
-
Biohaven (BHVN.NYSE), Zosano Pharma (ZSAN.Q), Lundbeck (HLUYY.OTC) tackle a $41 billion problem that cruelly targets women
“More than 4 million adults experience chronic daily migraine – with at least 15 migraine days per month,” states The Migraine Research Foundation, “It affects 39 million people in the U.S. and 1 billion worldwide.”
